Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study

BACKGROUND: The 3-weekly combination of trastuzumab and paclitaxel has been approved for the treatment of advanced breast cancer based on a large pivotal study. However, mono and combination chemotherapy trials suggest that weekly paclitaxel has a better therapeutic index, especially in the palliati...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: John, Matthias, Hinke, Axel, Stauch, Martina, Wolf, Heiner, Mohr, Benno, Hindenburg, Hans-Joachim, Papke, Jens, Schlosser, Joachim
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2012
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3443018/
https://ncbi.nlm.nih.gov/pubmed/22559145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-165
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker